SATIS_1170x120_1-25-21

Patrick Barry

Endo makes changes to executive team

Endo makes changes to executive team

DUBLIN, Ireland — Endo International plc has announced executive changes in its U.S. branded drug and research-and-development units. Endo said Patrick Barry has been appointed as senior vice president of U.S. branded pharmaceuticals effective immediately and Matthew Davis as senior vice president of R&D for branded pharmaceuticals effective Jan. 3. Barry, who comes to Endo